✦ LIBER ✦

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

✍ Scribed by Gerich, John E; Bastien, Arnaud

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dapagliflozin: A Novel Sodium-Glucose Co

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Differentiating sodium-glucose co-transp

✍ Washburn, William N; Poucher, Simon M 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 634 KB

Dapagliflozin for the Treatment of Type

✍ Aylsworth, A.; Dean, Z.; VanNorman, C.; Nkemdirim Okere, A. 📂 Article 📅 2014 🏛 Harvey Whitney Books Company 🌐 English ⚖ 282 KB

Pharmacokinetics and pharmacodynamics of

✍ S. Kasichayanula; M. Chang; M. Hasegawa; X. Liu; N. Yamahira; F. P. LaCreta; Y. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Dapagliflozin: A Once-Daily Oral Therapy

✍ Idris, ; Khalid Jadoon, 📂 Article 📅 2011 🏛 Libertas Academica 🌐 English ⚖ 631 KB

Empagliflozin, a sodium glucose co-trans

✍ Lamos, Elizabeth M; Younk, Lisa M; Davis, Stephen N 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 308 KB